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Implications of All the Available Evidence:
Subjective assessment of functional capacity should not be used for preoperative risk evaluation. This commonly employed practice does not accurately identify patients with poor fitness or those at elevated risk for postoperative morbidity and mortality. As alternatives, clinicians can consider more objectives measures, such as DASI questionnaires and NT pro-BNP testing for evaluating perioperative cardiac risk, and perhaps CPET to predict complications after major elective non-cardiac surgery.
SUMMARY
Background: Functional capacity is an emphasized component of risk assessment for major surgery. Doctors' clinical assessment of patients' functional capacity has uncertain accuracy.
Methods: This international prospective cohort study at 25 hospitals recruited adults (≥40 y) scheduled for major non-cardiac surgery. Functional capacity was subjectively assessed as <4 (poor), 4 to 10 (moderate), or >10 (good) metabolic equivalents. Participants completed the Duke Activity Status Index (DASI) questionnaire, cardiopulmonary exercise testing (CPET) to measure peak oxygen consumption (VO 2 peak), and blood testing for N-terminal pro-B-type natriuretic peptide (NT pro-BNP). Main outcomes were 30-day death or myocardial infarction (primary outcome), one-year death (secondary outcome), moderate-or-severe postoperative complications, and 30-day death or myocardial injury. Prognostic accuracy was evaluated using logistic regression, receiver-operating-characteristic curves and net risk reclassification.
Findings:
Of 1401 participants, 2·0% experienced 30-day death or myocardial infarction, 2·7% experienced one-year death, 13·9% experienced complications, and 12·6% experienced 30-day death or myocardial injury. Subjective assessment had 19·2% (95% CI, 14·2% -25·0%) sensitivity and 94·7% (93·2% -95·9%) specificity for identifying the inability to attain 4 metabolic equivalents during CPET. Subjective assessment was not associated with outcomes. DASI was associated with the primary outcome (p=0·03), and 30-day death or myocardial injury (p=0·05). NT pro-BNP was associated with 30-day death or myocardial injury (p=0·003), and one-year death (p=0·001). VO 2 peak was associated with complications (p=0·007).
Interpretation:
Subjectively assessed functional capacity should not be used for preoperative risk evaluation. Clinicians should instead consider DASI or NT pro-BNP for cardiac risk evaluation, and CPET for predicting postoperative complications. 
INTRODUCTION
International clinical practice guidelines emphasise evaluation of preoperative cardiopulmonary fitness, or functional capacity, as a critical component of the assessment of patients' risks for major morbidity and mortality after surgery. 1, 2 For example, the American College of Cardiology and American Heart Association recommend that patients proceed directly to elective intermediate and major non-cardiac surgery if they are capable of more than four metabolic equivalents of activity without symptoms. 1 The current usual standard of care for assessing preoperative functional capacity involves doctors evaluating patients and then making subjective estimates of their fitness (hereafter referred to as 'subjective assessment'). While easily implementable into clinical practice, subjective assessment has limitations, including poor agreement with validated measures of functional capacity, 3 and relatively poor accuracy when predicting postoperative death or complications. 4, 5 These limitations point to the need for better alternatives to assess preoperative functional capacity.
Possible options are cardiopulmonary exercise testing (CPET), which has been described as a "gold standard" non-invasive assessment of exercise tolerance, 6 and the Duke Activity Status Index (DASI), 7 which is a standardised questionnaire correlated with gold-standard measures of functional capacity. Additionally, while no blood test can directly measure functional capacity, N-terminal pro-B-type natriuretic peptide (NT pro-BNP) concentrations might indirectly fulfil this role by serving as an integrated marker of cardiac dysfunction. 8 We therefore conducted the Measurement of Exercise Tolerance before Surgery (METS) study to compare preoperative subjective assessment, CPET, DASI, and NT pro-BNP for predicting death or complications after major elective non-cardiac surgery.
METHODS

Study Design
The METS study was a multicentre prospective cohort study conducted in Canada, the United Kingdom, Australia, and New Zealand. Its objectives, design, and methods have been previously reported. 9 All participants provided written informed consent, and each centre obtained research ethics board approval before commencing recruitment. Details of the methods are presented in the Online Appendix.
Participants and Procedures
Participants were aged 40 years or older, scheduled for elective non-cardiac surgery under general and/or regional anaesthesia with a minimum of an overnight hospital stay, and deemed to have one or more risk factors for cardiac complications or coronary artery disease (Tables S1 and   S2 -Online Appendix). During the period from recruitment to one day before surgery, participants underwent symptom-limited incremental CPET on a computer-controlled, electromagnetically braked cycle ergometer using a standardised protocol (Online Appendix). 9 This assessment usually occurred during a separate hospital visit after the date of recruitment.
Based on a protocolised evaluation of the plotted CPET data, trained investigators at each centre determined both the peak oxygen consumption (VO 2 peak) and anaerobic threshold (AT).
Participants also underwent three other preoperative assessments of functional capacity. First, responsible anaesthesiologists in the preoperative assessment clinic (on date of recruitment) or operating theatre (on day of surgery) were asked to make a subjective judgment of participants' functional capacity after conducting their usual preoperative history. Subjectively assessed functional capacity was classified as 'poor' (<4 metabolic equivalents), 'moderate' (4 to 10 metabolic equivalents), and 'good' (>10 metabolic equivalents). The 'poor' category included cases where anaesthesiologists remained uncertain about patients' functional capacity after conducting their usual preoperative history, typically due to pre-existing conditions such as arthritis or peripheral arterial disease. 1 Second, participants completed the DASI questionnaire on the date of recruitment (Online Appendix - Table S3 ). Third, blood samples were drawn at any point between recruitment and surgery to measure serum NT pro-BNP concentrations. These samples were stored at -70°C to -80°C in each study site, and then analysed at the Aberdeen Royal Infirmary (Aberdeen, UK) using the Siemens Vista™ immunoassay analyser (Siemens Healthcare Diagnostics Ltd, Frimley, UK). Participants, healthcare providers and outcome adjudicators were blinded to CPET and NT pro-BNP results, while healthcare providers and outcome adjudicators were blinded to DASI scores. The exceptions were cases of myocardial ischaemia or significant new arrhythmias during CPET, in which case these specific findings, but not VO 2 peak or AT, were revealed to healthcare providers.
After surgery, participants underwent daily electrocardiograms and blood sampling to measure troponin and creatinine concentrations, until the third postoperative day or hospital discharge (whichever came first). Research personnel followed participants daily throughout their hospital stay to ascertain the presence of specific complications (Online Appendix - Table S4 ). The severity of complications was further categorised as mild, moderate, severe or fatal using a modified Clavien-Dindo classification scheme. 10, 11 After hospital discharge, participants were contacted at 30 days and one year after surgery to ascertain vital status. Details of the follow-up process are presented in the Online Appendix.
Study Outcomes
The primary outcome was death or myocardial infarction within 30 days after surgery, while the secondary outcome was death within one year after surgery. Myocardial infarction was diagnosed by an adjudication committee that used the Third Universal Definition of Myocardial Infarction while remaining blinded to CPET, DASI, and NT pro-BNP results. 12 Other outcomes of interest were death or myocardial injury within 30 days after surgery, and moderate-or-severe (including fatal) complications during the index hospitalisation. Myocardial injury was defined as postoperative troponin concentrations exceeding both the 99 th percentile of the normal reference population, and the threshold at which the assay coefficient of variation was 10%.
Moderate-or-severe complications were included as an endpoint because these events have been associated with poor preoperative functional capacity, especially as measured objectively by CPET.
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Statistical Analyses
In the primary analysis, all participants who undertook both CPET and surgery were included, and CPET performance was characterised by VO 2 peak. For each outcome of interest, we built separate nested logistic regression models that sequentially included baseline clinical characteristics, and then followed by the exposure of interest (i.e. subjective assessment, VO 2 peak, AT, DASI, or NT pro-BNP). We modelled NT pro-BNP concentrations using a logarithmic transformation to reduce the potential influence of extreme values within its highly-skewed distribution. The statistical significance of prognostic information from additional predictors was based on the increase in log likelihood of the "larger" model. For the models predicting the primary and secondary outcomes, the baseline variable was the validated Revised Cardiac Risk Index (RCRI) score. 15, 16 In the model predicting 30-day death or myocardial injury, the baseline variables were age, sex, and RCRI score. The baseline variables in the model predicting moderate-or-severe complications were age, sex, and high-risk surgery, which was defined as intra-peritoneal, intra-thoracic, or supra-inguinal vascular procedures. 15 These covariates were selected a priori based on prior evidence, their inclusion in guidelinerecommended assessment algorithms, 1, 17 and the need to prevent model overfitting. 18 Additionally, the covariates mirror clinically-sensible factors typically considered during preoperative evaluation. We calculated the area under the receiver-operating-characteristic (ROC) curve of models with successively more predictors, as well as models with only the individual exposure of interest (e.g., VO 2 peak). Prognostic information from these models was compared using the continuous net reclassification improvement (NRI) statistic and area under the ROC curve. 19, 20 The sample size calculation was based on comparing the area under the curve (AUC) of ROC curves for VO 2 peak versus subjective assessment with respect to predicting 30-day myocardial infarction or death. During the design of the METS study, a required sample size of 1180 was initially calculated based on the underlying assumptions of an outcome event rate of 8%, correlation of 0·5 between VO 2 peak and subjective assessment, 7 AUC of 0·65 for subjective assessment, AUC of 0·75 for VO 2 peak, and 90% power to detect this difference in AUC values (2-sided alpha of 0·05). To account for 10% of participants not undertaking CPET or surgery, we aimed to recruit 1312 participants. After recruiting about half of the original planned sample size, this sample size calculation was re-evaluated based on two factors identified in the accumulating study data. First, we found that about 20% of participants did not either undertake CPET or undergo their planned surgeries. Second, the event rate for the primary outcome was instead projected to be approximately 5%. The overall sample size was therefore increased to 1723 participants to account for up to 20% of recruited individuals not being eligible for the primary analysis, and a primary outcome event rate of 5%, while retaining the power of 80%.
Importantly, we remained blinded to all data on the principal exposures (i.e., CPET results, DASI scores, NT pro-BNP concentrations) during this sample size re-estimation.
Analyses were conducted using the R statistical language (Version 3.4.0), statistical significance was defined by a two-tailed p-value <0·05 and no adjustments were made for multiple comparisons. 21 Since missing data were very uncommon (<4%), a complete case analysis was performed. 22 Additionally, these missing data pertained to baseline information that was likely missing completely at random.
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RESULTS
Participant Characteristics
From March 2013 to March 2016, 1741 patients were recruited at 25 hospitals, with 1401 (80·5%) undergoing CPET and surgery ( Figure 1 ). Of these 1401 participants in the primary cohort, 1399 (99·9%) completed 30-day follow-up and 1378 (98·4%) completed one-year follow-up. The characteristics of the cohort are presented in Table 1 . 24 Their mean age was 64 years, 39% were female, and 91% were classified as American Society of Anesthesiologists Physical Status (ASA-PS) 2 or 3. Most participants underwent major abdominal, pelvic, or orthopaedic procedures. Arterial lines were inserted in 49% of participants, while central venous catheters were inserted in 15%. After surgery, 24% of participants were admitted to critical care or monitored bed units.
Assessments of Preoperative Functional Capacity
The CPET exercise protocol was terminated early in 11% of participants, with the most common reasons being inability to pedal, fatigue, or a safety-based indication (Table 2) . A VO 2 peak was measurable in 1356 (97%) participants, with the mean being 19·2 mL/kg/min (SD 6·5). By comparison, 1275 (91%) participants had a measurable AT, with a mean of 12·6 mL/kg/min (SD 4·1). Adverse events during CPET were experienced by 8% of participants (Table 2) , with 27 cases meeting criteria for unblinding. The clinical sequelae of these events are presented in Table   S5 (Online Appendix).
In addition, 1351 (96·4%) participants underwent subjective assessment of functional capacity, 1396 (99·6%) completed DASI questionnaires, and 1347 (96·1%) had NT pro-BNP concentrations measured (Table S6 -Online Appendix). About 8% of participants (n=107) were subjectively judged to have poor preoperative functional capacity, 16% (n=230) had a VO 2 peak <14 mL/kg/min (equivalent to <4 metabolic equivalents), and 30% (n=426) had an AT below the suggested high-risk threshold of 11 mL/kg/min. 25 The characteristics of participants within strata defined by VO 2 peak is presented in Table S7 (Online Appendix). A subjective assessment of poor functional capacity had a sensitivity of 19·2% (95% CI, 14·2% -25·0%) for identifying VO 2 peak <14 mL/kg/min, while its specificity was 94·7% (93·2% -95·9%).
When stratified by subjectively assessed functional capacity, VO 2 peak and DASI values were 
Postoperative Outcomes
After surgery, 194 (13·9%) participants suffered in-hospital moderate-or-severe complications.
By 30 days after surgery, 5 (0·4%) participants had died, 24 (1.7%) experienced myocardial infarction, 28 (2·0%) experienced the primary outcome of death or myocardial infarction, and 176 (12·6%) experienced death or myocardial injury. By one year after surgery, 38 (2·7%) participants had died. Among moderate-or-severe complications, the more frequent events were respiratory failure, pneumonia, surgical site infection, re-operation, and unexpected critical care unit admission (Table S9 -Online Appendix).
Prognostic Performance of Preoperative Functional Capacity Assessments
Subjective assessment ratings, VO 2 peak, AT, DASI scores and NT pro-BNP concentrations within strata defined by the four outcomes of interest are presented in Tables S8 and S9 (Online Appendix). Subjectively assessed preoperative functional capacity had no statistically significant adjusted association with the four main study outcomes (Table S10 -Online Appendix).
The adjusted associations of VO 2 peak, AT, DASI scores and NT pro-BNP concentrations with the main outcomes of interest, as well as continuous NRI statistics describing their incremental predictive performance, are presented in Table 3 . For VO 2 peak, a statistically significant adjusted association and significant risk reclassification was observed only with respect to moderate-or-severe complications. Anaerobic threshold showed no statistically significant association or risk reclassification with the main outcomes. DASI scores showed statistically significant adjusted associations with (i) 30-day death or myocardial infarction and (ii) 30-day death or myocardial injury. Additionally, it showed significant risk reclassification with 30-day death or myocardial injury. Conversely, NT pro-BNP concentrations showed statistically significant adjusted associations and significant risk reclassification with both (i) 1-year death and (ii) 30-day death or myocardial injury.
Post-Hoc Subset Analysis in Body Cavity Surgery
To address whether preoperative functional capacity might have better prognostic value in more invasive surgical procedures, a post-hoc subset analysis was performed in body cavity surgery, which was defined as intrathoracic, intraperitoneal, retroperitoneal or pelvic (i.e., urologic or gynaecologic) procedures. The characteristics and outcomes of the 912 participants in this subset are presented in Table S11 (Online Appendix). When the main study analyses were repeated in this subset, the results remained qualitatively unchanged (Table S12 -Online Appendix).
DISCUSSION
In this international prospective cohort study of non-cardiac surgery patients, preoperative subjective assessment neither accurately identified patients with poor cardiopulmonary fitness, nor predicted postoperative morbidity and mortality. The DASI questionnaire improved prediction of 30-day myocardial infarction or death, and 30-day myocardial injury or death;
while NT pro-BNP concentrations improved prediction of 30-day myocardial injury or death, and 1-year death. Formal evaluation of cardiopulmonary fitness, based on VO 2 peak during CPET, improved prediction of moderate-or-severe postoperative complications.
Interpretation and Comparison with Prior Research
In the METS study, subjective assessment of preoperative functional capacity consistently demonstrated poor performance. While it had construct validity, in that VO 2 peak was generally lower in patients judged to be less fit, subjective assessment correctly identified only 16% of patients who achieved a VO 2 peak less than 14 mL/kg/min, which is consistent with less than four metabolic equivalents. Further, subjective assessment did not predict postoperative myocardial infarction, myocardial injury or complications, confirming a prior single-centre retrospective cohort study that relied on administrative database for outcome ascertainment. 5 Based on these findings, subjective assessment should not be used to assess patients' risks of major postoperative cardiac complications.
Notably, more objective evaluation of cardiopulmonary fitness with CPET did not improve most aspects of preoperative risk assessment. Consistent with prior evidence, 13 The METS study found the DASI questionnaire to have construct validity as a measure of functional capacity in surgical patients, consistent with prior research. 32 Importantly, it also improved prediction of postoperative myocardial infarction and myocardial injury. Our findings confirm non-operative data indicating enhanced risk prediction using this questionnaire, 33, 34 support guideline suggestions for using objective scales to evaluate functional capacity, 1 and point to opportunities for straightforward improvements in clinical practice. Specifically, the simple DASI questionnaire can be easily implemented into most perioperative practice settings, although further work is needed to define optimal risk-specific thresholds in DASI scores, and develop reliable non-English versions of the questionnaire. 35 An important area of residual uncertainty is why DASI scores were associated postoperative cardiac events, yet VO 2 peak was not. Given the only moderate correlation between DASI scores and VO 2 peak, a possible explanation is that DASI measures also somewhat different constructs, such as musculoskeletal strength, frailty, and self-imposed physical limitations. 36 Confirming a previous individual patient data meta-analysis, 37 elevated preoperative NT pro-BNP concentrations were associated with increased risks of postoperative 30-day death or myocardial injury in the METS study cohort; additionally, elevated concentrations also predicted increased one-year mortality. These findings support recommendations in recent practice guidelines to incorporate natriuretic peptide testing into preoperative risk assessment strategies. 17 Notably, we found only slight-to-fair correlation between NT pro-BNP concentrations and measures of exercise capacity (i.e., VO 2 peak, DASI). This low correlation suggests that NT pro-BNP measures a construct distinct from exercise capacity, and raises that possibility for enhancing preoperative assessment by combining measures of functional capacity and NT pro-BNP in future risk prediction models.
Limitations
Our study has several limitations. First, despite increasing the original projected sample size, the event rates for the primary and secondary outcomes were less than anticipated. To some extent, the risks of 30-day death (i.e., 0.4%) and 30-day death and or myocardial infarction (i.e., 2.0%) in the METS study are representative of contemporary elective major non-cardiac surgery in high-income countries, as suggested by several studies published after the design of our study.
For example, in the International Surgical Outcomes (ISOS) prospective cohort study of 44, 814 adults having elective inpatient surgery across 27 high and middle income countries, the risk of in-hospital 30-day death was 0.5%. 11 Similarly, in the Vascular Events In Noncardiac Surgery
Patients Cohort Evaluation (VISION) prospective cohort study of 15,133 patients having inpatient non-cardiac surgery in eight high and middle income countries, the risk of 30-day mortality after elective surgery was 1.2%. In this same VISION cohort, the overall risk of myocardial infarction was about 3.3%. 38 Since emergency surgery constituted 14% of the cohort, and is associated with a three-fold higher risk of myocardial infarction, 39 the risk of myocardial infarction after elective surgery in the VISION study was likely about 2.6%. Thus, the event rates in the METS study are consistent with other contemporary major non-cardiac surgery samples. Nonetheless, to help address this reduced statistical power, we analysed the association of the exposures of interest with two more frequent outcomes: myocardial injury and moderateor-severe postoperative complications. Myocardial injury and postoperative complications are clinically and prognostically important outcomes. [39] [40] [41] [42] Our general findings with respect to prediction of 30-day myocardial infarction or death were qualitatively unchanged in the complementary analysis pertaining to 30-day myocardial injury or death.
Second, despite significant efforts by research personnel and study investigators, the consent rate among otherwise eligible patients in the METS study was 27%. Nonetheless, this consent rate is somewhat unsurprising when viewed from the perspective of the study setting (i.e., anxious patients awaiting major surgery within a short time frame) and procedures (i.e., strenuous exercise testing solely for research purposes). It is also consistent with several large contemporary prospective studies in surgical patients that had arguably more straightforward study procedures. For example, consent rates were 30% in the Perioperative Ischemic Evaluation 2 (POISE-2) trial of aspirin and clonidine in non-cardiac surgery, 43 and 36% in the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial in cardiac surgery. 44 Third, the primary analyses relied on VO 2 peak and AT determined by trained investigators at each individual centre. It is possible that central adjudication of CPET results might have led to different determinations of VO 2 peak and AT. Nonetheless, given that the METS study was designed to be pragmatic and generalisable, our main analyses better represent the prognostic accuracy of VO 2 peak or AT in real world clinical practice. Fourth, the preoperative predictive models in this study had generally low-to-moderate discrimination, with AUC values of 0.74 or lower. This observation is, in part, explained by the lower-than-expected outcome event rate, which limited the number of covariates included in regression models. Nonetheless, the discrimination of these models is comparable to recent research, such as a prospective cohort study where the combination of RCRI score and preoperative coronary computed tomographic angiography had an AUC of 0.66 for predicting 30-day death or myocardial infarction. 45 Fifth, each hospital used its own preferred troponin assay to detect myocardial infarction or myocardial injury. This pragmatic approach is consistent with many contemporary multicentre perioperative studies. 43, 46 Furthermore, variation in troponin assays does not influence the prognostic importance of myocardial infarction or myocardial injury, 39,41 and should not have biased the association between the study exposures and outcomes.
Future Directions
In combination with previous data, the results of the METS study now suggest that DASI scores and natriuretic peptides, such as NT pro-BNP, should supplant subjective assessment for the estimation of perioperative cardiac risk for major non-cardiac surgery. More research is required to define optimal thresholds for these measures, and determine how they should be utilised in combination with other prognostically important information, including alternative preoperative biomarkers (e.g., high-sensitivity troponin). 47 These other biomarkers might also help address, in part, the limitations of NT pro-BNP as a prognostic biomarker in the presence of obesity, 48 chronic renal kidney, 49 or heart failure with preserved ejection fraction.
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Our findings also indicate that CPET, specifically VO 2 peak, can be used to identify patients at elevated risk for postoperative complications. Research remains needed to define optimal thresholds in VO 2 peak, determine the role of central expert adjudication to improving its prognostic accuracy, evaluate novel CPET-derived metrics of cardiopulmonary fitness (e.g., heart rate recovery), and assess possible inter-relationships of CPET-derived metrics with prognostically important comorbidities. For example, lower haemoglobin concentrations are associated with both elevated perioperative risk and reduced VO 2 peak.
51,52
Conclusions
Preoperative subjective assessment of functional capacity should not be used in clinical practice because it does not accurately identify patients with poor fitness or those at elevated risk for morbidity and mortality after major elective non-cardiac surgery. Clinicians can instead consider more objectives measures, such as DASI questionnaires and NT pro-BNP testing for evaluating perioperative cardiac risk, and perhaps CPET to predict complications after major elective noncardiac surgery. presents the DASI score distribution among the 50 participants with missing subjective assessments. The wide-ranging distribution in this subgroup suggests that these values were missing completely at random.
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C. Panel C is a scatter plot presenting the association of VO 2 peak (y-axis) and DASI scores (xaxis). The Spearman correlation coefficient between DASI scores and VO 2 peak is 0·41 (p<0·001). The blue line is a line of best fit (estimated using cubic regression splines), while the grey shaded zone represents its 95% confidence limits.
D. Panel D is a scatter plot presenting the association of VO 2 peak (y-axis) and NT pro-BNP concentrations (x-axis on a log 10 scale). The Spearman correlation coefficient between NT pro-BNP and VO 2 peak is -0·21 (p<0·0001). The blue line is a line of best fit (estimated using cubic regression splines), while the grey shaded zone represents its 95% confidence limits. Critical care unit or monitored bed unit 331 (24%) 1 Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; ASA-PS, American Society of Anesthesiologists Physical Status; eGFR, estimated glomerular filtration rate * Current smoker or quit within previous one year † Prior diagnosis of asthma, reactive airways disease, chronic obstructive lung disease, chronic bronchitis, or emphysema ‡ Previous or scheduled major joint replacement surgery § Indication for surgery was treatment of cancer ¶ Estimated glomerular filtration rate was calculated using the preoperative serum creatinine concentration and Chronic Kidney Disease Epidemiology Collaboration equation. 24 ** Revised Cardiac Risk Index scores were calculated using the original definitions of diabetes mellitus (i.e., requirement for insulin therapy) and renal insufficiency (i.e., creatinine concentration >176 µmol/L) were employed. 15 When determining Revised Cardiac Risk Index scores, any individual with missing preoperative creatinine concentration data was assumed as having a concentration ≤176 µmol/L 
